Pedro Miguel Salcedo-Gómez

GRL-0519, a Novel Oxatricyclic Ligand-Containing Nonpeptidic HIV-1 Protease Inhibitor (PI), Potently Suppresses Replication of a Wide Spectrum of Multi-PI-Resistant HIV-1 Variants <i>In Vitro</i>

Masayuki Amano, Yasushi Tojo, Pedro Miguel Salcedo-Gómez et al. · Antimicrobial Agents and Chemotherapy · 2013 · 28 citations · Full text

Immunology, Molecular Biology, Wide Spectrum +18

GRL-09510, a Unique P2-Crown-Tetrahydrofuranylurethane -Containing HIV-1 Protease Inhibitor, Maintains Its Favorable Antiviral Activity against Highly-Drug-Resistant HIV-1 Variants in vitro

Masayuki Amano, Pedro Miguel Salcedo-Gómez, Ravikiran S. Yedidi et al. · Scientific Reports · 2017 · 19 citations · Full text

A Modified P1 Moiety Enhances <i>In Vitro</i> Antiviral Activity against Various Multidrug-Resistant HIV-1 Variants and <i>In Vitro</i> Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413

Masayuki Amano, Pedro Miguel Salcedo-Gómez, Rui Zhao et al. · Antimicrobial Agents and Chemotherapy · 2016 · 14 citations · Full text

Novel Central Nervous System (CNS)-Targeting Protease Inhibitors for Drug-Resistant HIV Infection and HIV-Associated CNS Complications

Masayuki Amano, Pedro Miguel Salcedo-Gómez, Ravikiran S. Yedidi et al. · Antimicrobial Agents and Chemotherapy · 2019 · 12 citations · Full text

A Novel Tricyclic Ligand-Containing Nonpeptidic HIV-1 Protease Inhibitor, GRL-0739, Effectively Inhibits the Replication of Multidrug-Resistant HIV-1 Variants and Has a Desirable Central Nervous System Penetration Property <i>In Vitro</i>

Masayuki Amano, Yasushi Tojo, Pedro Miguel Salcedo-Gómez et al. · Antimicrobial Agents and Chemotherapy · 2015 · 11 citations · Full text